Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Epithelial Cell
DISEASE(S): Malignant Neoplasm Of Ovary
SUBMITTER: Jolene Duda
LAB HEAD: Stefani N Thomas
PROVIDER: PXD044705 | Pride | 2023-12-28
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
20230120_Vehicle_NT_R1_F1.raw | Raw | |||
20230120_Vehicle_NT_R1_F2.raw | Raw | |||
20230120_Vehicle_NT_R1_F3.raw | Raw | |||
20230123_CD12_NT_R1_F1.raw | Raw | |||
20230123_CD12_NT_R1_F2.raw | Raw |
Items per page: 1 - 5 of 227 |
ACS pharmacology & translational science 20231116 12
High-grade serous ovarian cancer (HGSOC) is the deadliest gynecologic malignancy in women. The low survival rate is largely due to drug resistance. Approximately 80% of patients who initially respond to treatment relapse and become drug-resistant. The lack of effective second-line therapeutics remains a substantial challenge for BRCA-1/2 wild-type HGSOC patients. Histone Deacetylases (HDACs) are promising targets in HGSOC treatment; however, the mechanism and efficacy of HDAC inhibitors are unde ...[more]